Similar results were also observed for another publicly available transcriptomic dataset for 416 bladder tumors (271 with FGFR3 mutations) and eight normal samples (Hedegaard et al, 2016; Appendix Fig S1A and B), suggesting that mutated FGFR3 may also regulate MYC expression in human bladder carcinomas. The gene discussed is FGFR3; the disease is urinary bladder neoplasm.